Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DECADRON W/ XYLOCAINE

DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE

Standard Dose
EQ 4MG PHOSPHATE/ML;10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DECADRON W/ XYLOCAINE is listed in Drugs@FDA under application 013334 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 4MG PHOSPHATE/ML;10MG/ML Sponsor MERCK Submission history Latest submission status date: 1996-03-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview DECADRON W/ XYLOCAINE is listed in Drugs@FDA under application 013334 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 4MG PHOSPHATE/ML;10MG/ML Sponsor MERCK Submission history Latest submission status date: 1996-03-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.